Effects of Tourniquet Use on Physical Function and Performance in Primary Total Knee Arthroplasty
Primary Purpose
Knee Osteoarthritis
Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Non-tourniquet assisted TKA
Tourniquet assisted TKA
Sponsored by
About this trial
This is an interventional treatment trial for Knee Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Knee Osteoarthritis both clinically and radiologically according to the "Ahlbäck classification system".
- Patients who can tolerate spinal anesthesia
Exclusion Criteria:
- Patients with rheumatoid arthritis.
- Patients with BMI > 35.
- History of major knee operations.
- Malignancy.
- Known muscle disease.
- History of deep vain thrombosis (DVT), or other blood coagulation disorders.
- Symptomatic bilateral OA, with planned surgery of the contra lateral knee within a year.
Sites / Locations
- Odense University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Non-tourniquet assisted TKA
Tourniquet assisted TKA
Arm Description
Outcomes
Primary Outcome Measures
Change in self reported physical function. Assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire subscale for, Function in Daily Living (ADL).
Further assessments: Baseline, 14 days and a 6 and 12 months follow up. KOOS is a patient-reported outcome measure with good evidence of reliability, validity and responsiveness in different population with varying pathologies, injury durations, and activity levels (http://www.koos.nu).
Secondary Outcome Measures
Change in the Knee injury and Osteoarthritis Outcome Score (KOOS)
The remaining 4 subscales for pain, other symptoms, function in sport and recreation, and knee related quality of life.
Global perceived effect (GPE) score
In addition to pain and physical function the assessment by the patient of a global perceived effect of the treatment is a recommended responder criterion [4]. Patients will be asked to rate possible change in their condition since the initial administration (baseline) on a 7-point Likert-scale.
Change in physical performance (battery).
Physical performance-based measures will include; Passive knee range of motion, 30 s chair stand (number completed), 20 m normal-paced and fast-paced walk (time in sec.), and timed up and go (time in sec.)
Full Information
NCT ID
NCT01891266
First Posted
June 21, 2013
Last Updated
June 27, 2013
Sponsor
University of Southern Denmark
Collaborators
The Danish Rheumatism Association, Bevica Fonden
1. Study Identification
Unique Protocol Identification Number
NCT01891266
Brief Title
Effects of Tourniquet Use on Physical Function and Performance in Primary Total Knee Arthroplasty
Official Title
Effects of Tourniquet Use on Physical Function and Performance in Primary Total Knee Arthroplasty: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2013
Overall Recruitment Status
Unknown status
Study Start Date
September 2013 (undefined)
Primary Completion Date
November 2014 (Anticipated)
Study Completion Date
September 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Southern Denmark
Collaborators
The Danish Rheumatism Association, Bevica Fonden
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Background:
Osteoarthritis (OA) is the most common joint disease that causes symptomatic health problems in the elderly population. For some patients with knee OA, total knee arthroplasty (TKA) may be the only option that offers the possibility of reestablishing the patient's life quality.
Surgery of TKA usually takes place in a complete bloodless field established by a tourniquet around the thigh. The method aims to reduce blood loss and give the surgeon better visibility during the operation. The method is, however, not without side effects as patients often experience severe pain and swollen leg in the time after surgery. Furthermore, has the method shown decidedly muscle- and nerve damage followed by prolonged rehabilitation and reduced physical function.
It is, however, possible to perform the operation without the use of the tourniquet.
Aim and hypothesis:
The aim of the present study is to assess the effects of tourniquet use in TKA on physical function, early rehabilitation, pain and opioid consumption.
Hypotheses H1: TKA without tourniquet leads to better physical function and early rehabilitation.
H2: TKA without tourniquet causes less pain and opioid consumption H3: Recovery of mechanical lower limb function post TKA is faster without use of tourniquet.
Methods:
80 patients (40 in each group) all eligible for TKA will be consecutively recruited and randomized to A) TKA without tourniquet, B) TKA with tourniquet. Subjects will be evaluated before the operation (baseline) and 14 days, 3, 6 and 12 months after the operation.
The primary outcome will be the change from baseline to 3 months in self-administered knee-function (KOOS-ADL subscale). Further, will we examine a number of pre-specified secondary outcomes, which include self-rated knee-related pain, symptoms, difficulty with sports and leisure activities, and quality of life. In addition, muscle function, physical performance, and the use of pain medication will be studied
Impact of the project:
The project design of this study will enable analyses for determining the impact of operating without tourniquet and whether such an intervention can in fact improve physical function, performance and quality of life within TKA patients. The results may impact notably on the patient level and possible redefine current surgical strategies. The societal perspective of the project is to remobilize patients faster, which may reduce hospital services and absence from work.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Non-tourniquet assisted TKA
Arm Type
Experimental
Arm Title
Tourniquet assisted TKA
Arm Type
Other
Intervention Type
Procedure
Intervention Name(s)
Non-tourniquet assisted TKA
Intervention Description
The intervention group will undergo non-tourniquet assisted total knee arthroplasty, which means that blood flow to the lower limb is maintained throughout surgery.
Intervention Type
Procedure
Intervention Name(s)
Tourniquet assisted TKA
Intervention Description
The procedure involves the use of a tourniquet around the thigh. During surgery the tourniquet will be inflated above the systolic blood pressure to ensure a complete bloodless surgical field.
Primary Outcome Measure Information:
Title
Change in self reported physical function. Assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire subscale for, Function in Daily Living (ADL).
Description
Further assessments: Baseline, 14 days and a 6 and 12 months follow up. KOOS is a patient-reported outcome measure with good evidence of reliability, validity and responsiveness in different population with varying pathologies, injury durations, and activity levels (http://www.koos.nu).
Time Frame
Endpoint 3 months
Secondary Outcome Measure Information:
Title
Change in the Knee injury and Osteoarthritis Outcome Score (KOOS)
Description
The remaining 4 subscales for pain, other symptoms, function in sport and recreation, and knee related quality of life.
Time Frame
Baseline, 14 days, 3 months (endpoint) and a 6 and 12 months follow up
Title
Global perceived effect (GPE) score
Description
In addition to pain and physical function the assessment by the patient of a global perceived effect of the treatment is a recommended responder criterion [4]. Patients will be asked to rate possible change in their condition since the initial administration (baseline) on a 7-point Likert-scale.
Time Frame
3 months (endpoint) and a 6 and 12 months follow up
Title
Change in physical performance (battery).
Description
Physical performance-based measures will include; Passive knee range of motion, 30 s chair stand (number completed), 20 m normal-paced and fast-paced walk (time in sec.), and timed up and go (time in sec.)
Time Frame
Baseline, 3 and 14 days, 3 months (endpoint) and a 6 months follow up
Other Pre-specified Outcome Measures:
Title
Change in mechanical muscle function
Description
Mechanical muscle function includes; Quadriceps strength (MVC), Rate of force development, surface electromyography, force steadiness.
Time Frame
Baseline, 3 and 6 months
Title
Change in 30-sec Maximal Repeated Unilateral Knee Bending
Description
Measures the maximum number of knee bends performed on one leg in 30 seconds and the ability to execute fast stretch shortening cycles over the knee joint.
Time Frame
Baseline, 3 and 6 months
Title
Change in Pain
Description
Self-reported pain: Pain intensity is measured using an 11-step visual analogue scale (VAS) (0 = no pain and 10 = worst possible pain). The VAS has been demonstrated to be reliable and valid in assessing the intensity of musculoskeletal knee pain [5].
Self-reported use of pain medication: The patient's use of pain medication will be registered.
Time Frame
Baseline and 1-14 days
Title
Muscle biopsies
Description
Two muscle biopsy samples (2 * 100 mg) will be acquired in a subgroup of the patients (2 x 10) during operation. One sample will be collected prior to applying the tourniquet, and a second sample will be collected prior to the removal of the tourniquet. Muscle tissue is frozen in liquid nitrogen and sent for analysis at the Institute of Sports Science and Clinical Biomechanics for mechanical characteristics, Ca2+-kinetics and markers of free oxygen radicals.
Time Frame
Baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Knee Osteoarthritis both clinically and radiologically according to the "Ahlbäck classification system".
Patients who can tolerate spinal anesthesia
Exclusion Criteria:
Patients with rheumatoid arthritis.
Patients with BMI > 35.
History of major knee operations.
Malignancy.
Known muscle disease.
History of deep vain thrombosis (DVT), or other blood coagulation disorders.
Symptomatic bilateral OA, with planned surgery of the contra lateral knee within a year.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rasmus Lohmann-Jensen, MSc
Phone
+45 22407697
Email
rlohmann-jensen@health.sdu.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Søren Overgaard, Professor
Phone
+45 65413889
Email
soeren.overgaard@ouh.regionsyddanmark.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rasmus Lohmann-Jensen, Cand. Scient
Organizational Affiliation
Odense University Hospital and University of Southern Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Søren Overgaard, Professor
Organizational Affiliation
Odense University Hospital and University of Southern Denmark
Official's Role
Study Chair
Facility Information:
Facility Name
Odense University Hospital
City
Odense
ZIP/Postal Code
5000
Country
Denmark
12. IPD Sharing Statement
Citations:
PubMed Identifier
24678741
Citation
Lohmann-Jensen R, Holsgaard-Larsen A, Emmeluth C, Overgaard S, Jensen C. The efficacy of tourniquet assisted total knee arthroplasty on patient-reported and performance-based physical function: a randomized controlled trial protocol. BMC Musculoskelet Disord. 2014 Mar 29;15:110. doi: 10.1186/1471-2474-15-110.
Results Reference
derived
Learn more about this trial
Effects of Tourniquet Use on Physical Function and Performance in Primary Total Knee Arthroplasty
We'll reach out to this number within 24 hrs